CAS NO: | 2652001-05-1 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | P-gp inhibitor 4 (Compound 8b) is a selectiveP-glycoproteinmodulator with anEC50of 94 nM. P-gp inhibitor 4 increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistantcancercells[1]. | ||||||||||||||||
IC50& Target | EC50: 94 nM (P-glycoprotein)[1] | ||||||||||||||||
体外研究 (In Vitro) | P-gp inhibitor 4 (Compound 8b) (0-1 μM, 48 h) significantly increases the cytotoxic effect of antineoplastic drug with co-administration[1]. Cell Proliferation Assay[1]
Cell Viability Assay[1]
| ||||||||||||||||
分子量 | 714.85 | ||||||||||||||||
Formula | C38H38N2O8S2 | ||||||||||||||||
CAS 号 | 2652001-05-1 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |